National Association of Testing Authorities, Australia
Mark Weir-Smith is a highly experienced professional in quality operations and regulatory affairs, currently holding senior leadership positions at NovaCina and LumaCina since January 2023, and at Bridgewest Perth Pharma since December 2022. Mark also serves as a Medical Assessor for the National Association of Testing Authorities in Australia since 2002, overseeing the accreditation of various testing and manufacturing bodies nationally. Previous roles include leadership positions at Western Diagnostic Pathology, Pfizer, and the Australian Red Cross Blood Service. Mark has contributed to the pharmaceutical industry as Vice President and Board Member of ISPE Australasia and has held senior roles at Sanofi Genzyme and Abbott. Educational qualifications include a Science degree from Curtin University and Business Organizational Leadership from Harvard Business School.
This person is not in the org chart
This person is not in any teams
National Association of Testing Authorities, Australia
The National Association of Testing Authorities, Australia (NATA) is the Australian authority that provides independent assurance of technical competence through a proven network of best practice industry experts for customers who require confidence in the delivery of their products and services. NATA provides assessment, accreditation and training services to laboratories and technical facilities throughout Australia and internationally. Visit our website at www.nata.com.au Find us on: Facebook: National Association of Testing Authorities, Australia Twitter: @NATAAUS Instagram: @nata.aus YouTube: NATA Australia